Clinical Trial Update: Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study - [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the Canadian Atrial Fibrillation Evaluation (CAFE) study evaluating atrial fibrillation treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED